NIH officials said they were given no advanced warning and less than an hour to post the memo publicly.
TOKYO-- ( BUSINESS WIRE )--Kaname Capital (hereinafter referred to as "we" or "our firm") owns more than 8.34% Proto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback